美国股票策略-市场展望演示材料-US Equity Strategy_ Market outlook - Presentation.pdf

本文分析对象：宏观/策略报告

⚠️ 数据可用性声明：宏观/策略报告为非上市公司，无公开市场数据和财务数据。以下分析基于研报原文（UBS (瑞银)）的定性描述及公开信息整理，不包含独立财务数据验证。

管理层核心观点

• 原文未涉及

产品与业务

• 原文未涉及

行业与竞争

• AI cycle early+ unprecedented: “we are 2yrs into a Tech spend cycle that have historically lasted 10yrs at ~20% CAGR.”
• “Stay long Semis: at a 25%+ growth rate, Semis trade at 0.9x P/E to sales CAGR and 0.7x P/E to EPS CAGR.”
• “Add Hyperscalers opportunistically: cloud sales backlogs are now > 100% of total sales, and P/E to sales CAGR is <1.5x lowest since 2013.”
• “Capex broadening over consumer broadening”: “> 45% of SPX firms forecast NTM capex up >10% while real wages are running at sub 1%.”
• “Long cap goods: Data center planned capacity up 115% y/y; capital goods orders 10%+ historically coincided with double digit 12mo returns.”
• “Long Transports: Freight cycle turning as mfg exits recession, with truckload pricing improving, rail volumes recovering and fuel costs falling.”
• “Financials over REITs: Fins payouts up ~50% y/y and total yield is ~5%, with upside from regulatory loosening, corporate borrowing and deals.”
• “Long Banks, IBs, Consumer Finance: Bank CFROIs up more than 300bp over two years and excess capital potentially reaching about $300bn.”
• “Wellness accelerating, policy uncertainty abating for Healthcare”: “Wellness spending >$7tr and growing 7%, while GLP1 adoption shifts consumption away from food/staples.”
• “Long Pharma/Biotech: Sales CAGRs rising ahead of the patent cliff as R&D supports pipelines and M&A is accelerating.”

机构观点与评级

• 市场展望“still bullish, growth not fully priced”。
• 目标价：“target 8100 on S&P 500 for '26 and 8900 for '27”。
• 核心推荐逻辑：“EPS driven rally”, “NTM is projected to rise 25% the next 18mo, and the multiple falls 1x”, “Valuation well supported: higher 3-5yr forward sales growth and CFROI point to a 24x S&P P/E based on our new framework”。

关键风险

• 原文未涉及

数据可用性说明

本报告由 HopeAlpha 根据研报原文自动摘抄整理。因数据源限制，未进行财务深度分析。